These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
940 related articles for article (PubMed ID: 30798063)
21. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
22. Improved oral delivery of insulin by PLGA nanoparticles coated with 5 Wang W; Yu C; Zhang F; Li Y; Zhang B; Huang J; Zhang Z; Jin L Biomed Mater; 2021 Oct; 16(6):. PubMed ID: 34571498 [TBL] [Abstract][Full Text] [Related]
23. Effects of surface modification of As Song X; You J; Shao H; Yan C Colloids Surf B Biointerfaces; 2018 Sep; 169():289-297. PubMed ID: 29793091 [TBL] [Abstract][Full Text] [Related]
24. Effect of a 2-HP-β-Cyclodextrin Formulation on the Biological Transport and Delivery of Chemotherapeutic PLGA Nanoparticles. Zheng K; Huang Z; Huang J; Liu X; Ban J; Huang X; Luo H; Chen Z; Xie Q; Chen Y; Lu Z Drug Des Devel Ther; 2021; 15():2605-2618. PubMed ID: 34168432 [TBL] [Abstract][Full Text] [Related]
25. Application of temporary agglomeration of chitosan-coated nanoparticles for the treatment of lung metastasis of melanoma. Lee SY; Koo JS; Yang M; Cho HJ J Colloid Interface Sci; 2019 May; 544():266-275. PubMed ID: 30852352 [TBL] [Abstract][Full Text] [Related]
26. Polymeric nanoparticles produced by electrohydrodynamic atomisation for the passive delivery of imatinib. Tsilova SL; Schreiber BE; Lever R; Parhizkar M Eur J Pharm Biopharm; 2024 Sep; 202():114412. PubMed ID: 39013491 [TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel coumarin-triazole hybrids and first evaluation of the 4-phenyl substituted hybrid loaded PLGA nanoparticles delivery system to the anticancer activity. Arvas B; Ucar B; Acar T; Varli HS; Arvas MB; Aydogan F; Yolacan C Nanotechnology; 2024 May; 35(30):. PubMed ID: 38636487 [TBL] [Abstract][Full Text] [Related]
28. Doxorubicin-loaded poly (lactic-co-glycolic acid) nanoparticles coated with chitosan/alginate by layer by layer technology for antitumor applications. Chai F; Sun L; He X; Li J; Liu Y; Xiong F; Ge L; Webster TJ; Zheng C Int J Nanomedicine; 2017; 12():1791-1802. PubMed ID: 28424550 [TBL] [Abstract][Full Text] [Related]
29. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models. Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435 [TBL] [Abstract][Full Text] [Related]
30. Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry. Wong C; Ho EA J Pharm Pharm Sci; 2024; 27():13148. PubMed ID: 39165831 [TBL] [Abstract][Full Text] [Related]
32. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H; Xie LQ; Qin J; Jia Y; Cai X; Nan W; Yang W; Lv F; Zhang QQ Colloids Surf B Biointerfaces; 2016 Feb; 138():1-9. PubMed ID: 26638176 [TBL] [Abstract][Full Text] [Related]
33. Chitosan/carboxymethylcellulose-stabilized poly(lactide-co-glycolide) particles as bio-based drug delivery carriers. Inphonlek S; Sunintaboon P; Léonard M; Durand A Carbohydr Polym; 2020 Aug; 242():116417. PubMed ID: 32564826 [TBL] [Abstract][Full Text] [Related]
34. Design of Astaxanthin-Loaded Core-Shell Nanoparticles Consisting of Chitosan Oligosaccharides and Poly(lactic- co-glycolic acid): Enhancement of Water Solubility, Stability, and Bioavailability. Liu C; Zhang S; McClements DJ; Wang D; Xu Y J Agric Food Chem; 2019 May; 67(18):5113-5121. PubMed ID: 31013074 [TBL] [Abstract][Full Text] [Related]
35. Cherry Extract from Beconcini D; Fabiano A; Di Stefano R; Macedo MH; Felice F; Zambito Y; Sarmento B Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30974730 [TBL] [Abstract][Full Text] [Related]
36. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes. Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850 [TBL] [Abstract][Full Text] [Related]
37. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells. Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232 [TBL] [Abstract][Full Text] [Related]
38. Enhanced Antitumor Efficacy of Curcumin-Loaded PLGA Nanoparticles Coated with Unique Fungal Hydrophobin. Sun L; Xu H; Xu JH; Wang SN; Wang JW; Zhang HF; Jia WR; Li LS AAPS PharmSciTech; 2020 Jun; 21(5):171. PubMed ID: 32529560 [TBL] [Abstract][Full Text] [Related]
39. PTX-loaded three-layer PLGA/CS/ALG nanoparticle based on layer-by-layer method for cancer therapy. Wang F; Yuan J; Zhang Q; Yang S; Jiang S; Huang C J Biomater Sci Polym Ed; 2018 Sep; 29(13):1566-1578. PubMed ID: 29749303 [TBL] [Abstract][Full Text] [Related]
40. Development and Evaluation of Multifunctional Poly(Lactic-co-glycolic acid) Nanoparticles Embedded in Carboxymethyl β-Glucan Porous Microcapsules as a Novel Drug Delivery System for Gefitinib. Li X; Wang J; Li S; Liu Z; Zheng Z; Zhang Y Pharmaceutics; 2019 Sep; 11(9):. PubMed ID: 31547272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]